The United States healthcare system is getting drastically revamped in 2025, with policy changes and reforms set to affect not just Americans but also international health systems. From Medicaid and Medicare reforms to value-based care (VBC) advancements, these changes have implications for healt...
The United States healthcare system is getting drastically revamped in 2025, with policy changes and reforms set to affect not just Americans but also international health systems. From Medicaid and Medicare reforms to value-based care (VBC) advancements, these changes have implications for health systems around the world.
Key Reforms in the US Healthcare System
Medicaid Overhaul: The Trump administration has put forth a plan to shift Medicaid funding to block grants or per-capita caps, which could save the federal government as much as $1.2 trillion over a decade. While supporters believe this will improve efficiency and state flexibility, opponents fear it may restrict access to vulnerable groups, such as children and the elderly.
Medicare and Drug Pricing: Drug price controls under the Inflation Reduction Act persist, with negotiations focusing on high-cost drugs. This aligns with bipartisan efforts to lower consumers' out-of-pocket expenses.
Value-Based Care (VBC): Republican and Democratic administrations have both highlighted VBC as a priority, with a focus on improving patient outcomes while containing costs. Paths to Success and ACO REACH models are being expanded to focus on health equity and community-based care.
Digital Transformation: Health systems are speeding up digital adoption with a focus on telehealth, AI diagnostics, and electronic health records. These technologies seek to eliminate inefficiencies and enhance patient engagement.
Global Implications
-
The US healthcare overhaul has ripple effects around the world:
-
Policy Inspiration: India and Brazil, among other nations, can learn from America's VBC focus and integration of digital health.
-
Pharmaceutical Impact: When the US negotiates reduced drug prices, global pharma companies will be under pressure to implement the same pricing strategy elsewhere.
-
Medical Innovation: More investment in US public health infrastructure and behavioral healthcare could lead to innovation that serves global healthcare systems.
Challenges Ahead
-
These reforms hold out the promise of progress, but challenges persist. Medicaid reductions can put a squeeze on state budgets, and digital transformation demands major investment, which smaller countries may not be able to match.
-
While the world looks on as these events transpire, the US healthcare overhaul provides lessons and warning signs for policymakers across the globe.
Sources: Deloitte Insights, JAMA Health Forum, KFF, AHA Advocacy Update, March 2025